Form 4: Synopsys Director Jeannine Sargent Receives Equity Award
Director Equity Grant
Director Jeannine Sargent was granted 453 shares of Synopsys common stock as part of an automatic equity incentive plan.
Summary
- Director Jeannine Sargent acquired 453 shares of Synopsys (SNPS) common stock on April 16, 2026.
- The shares were granted as an automatic award under the company's Amended and Restated Equity Incentive Plan.
- The shares are subject to vesting requirements tied to the first Annual Meeting following the grant date, contingent upon continued Board service.
- Following this transaction, the director holds 2,997 shares directly and 445 shares indirectly through a family trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries no significant market sentiment impact.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Standardized, automatic nature of the equity grant indicates established corporate governance practices.
Negatives
- None identified in this filing.
Risks
- Vesting of the shares is contingent upon continued service on the Board of Directors.
Future Outlook
The shares will vest on the date immediately preceding the first Annual Meeting following the grant date, provided the director remains in service.
Industry Context
StockSavvy.ai notes that automatic equity grants for non-employee directors are a standard practice in the technology sector to ensure board member retention and long-term alignment with corporate performance.
Comparison to Industry Standards
- The equity grant structure is consistent with standard corporate governance practices for S&P 500 technology companies.
- The use of automatic incentive plans is a common mechanism to avoid potential conflicts of interest in director compensation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Administrative | Appointment of substitute attorneys-in-fact (Mary Lai and Anthony Mawla) for SEC filing purposes. | 12/11/2025 | Minimal; purely administrative change to facilitate timely regulatory filings. |
Stakeholder Impact
- Shareholders: No material impact; reflects standard director compensation.
Next Steps
- Vesting of the 453 shares at the next Annual Meeting of Shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/19/2023 | Original Power of Attorney date for John Schwarz |
| 03/20/2023 | Original Power of Attorney date for multiple directors including Jeannine Sargent |
| 03/21/2023 | Original Power of Attorney date for Janice Chaffin and Bruce Chizen |
| 04/03/2023 | Original Power of Attorney date for Sudhindra Kankanwadi |
| 07/28/2023 | Original Power of Attorney date for Robert G. Painter |
| 12/11/2025 | Execution date of Substitute Power of Attorney documents |
| 04/16/2026 | Transaction date of the equity award |
| 04/17/2026 | Filing date of the Form 4 |
Keywords
Synopsys, SNPS, Director Compensation, Equity Incentive Plan, Insider Transaction, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.